Skip to content
Monday, November 16, 2026
UpdateNetPlus UK

Patients Coming Off Weight-Loss Injections Regain Weight Four Times Faster Than People Using Diet and Exercise

Image of pharmaceutical injection and scale
Obesity treatment involves long-term strategies.

Fresh analysis reveals that individuals who stop using blockbuster weight-loss injections like semaglutide or tirzepatide may regain reduced body mass far faster than those who halt conventional lifestyle plans.

Published data in a major health publication demonstrates that while overweight people frequently drop a large proportion of their total mass while on the medication, the mass returns at an estimated rate of 0.8 kg per month once they quit.

"Users using these treatments must be cognizant of the danger of rapid weight regain when the therapy concludes," stated lead investigator Dr. Susan Jebb.

Such speed of recovery means a return to starting mass in about one and a half years.

Analyzing Treatments

The research, which reviewed 37 of trials involving thousands of participants, contrasted the results of GLP-1 agonists with other pills.

Scientists note that individuals who shed pounds through diet and exercise generally have a more gradual creep back—around 0.1 kg a month—after stopping.

Understanding the Quick Regain

Doctors believe the mechanism of the drugs is key to understanding the heightened weight return.

The injections mimic a natural hormone called GLP-1, which controls hunger.

"Long-term administration of GLP-1 concentrations far above than normal could lead to the system to produce less of its endogenous hormone, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Stopping of this medication leads to hunger is unsuppressed, making binge eating a significant risk."

An Ongoing Issue?

Health authorities advise the injections for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.

Professionals say that, given the high risk of relapse, the therapy might need to be life-long.

This opinion is supported by pharmaceutical companies, who note that the results "highlight the persistent character of obesity," akin to managing conditions like diabetes.

User Testimonies

Individuals who have come off the medication describe a intense resurgence of cravings.

"It felt as if something flipping and you become ravenous," described a patient.

The struggle is worsened if patients have not developed permanent dietary or behavioural changes during treatment.

Growing Use

Recent estimates show that a significant number of people in the UK have used weight-loss jabs in the past year, with interest continuing to grow.

  • Use is more common among females than males.
  • The middle-aged age group shows the greatest usage rates.
  • A large proportion access the drugs through private healthcare rather than public health services.

Finally, clinicians stress that while the jabs are effective tools for weight loss, they are not a standalone cure and lasting health benefits hinges on combined lifestyle management.

By

Kristin Carter

A tech journalist and digital strategist with over a decade of experience covering UK tech innovations and cybersecurity trends.

UpdateNetPlus UK

Type to search articles.